Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$422M |
| 2 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$132M |
| 3 |
PPD
PPD, Inc. Common Stock
PPD
|
+$113M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$70M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$65.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$310M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$167M |
| 3 |
RP
RealPage, Inc.
RP
|
+$61M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$60.6M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$44.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.76% |
| 2 | Healthcare | 14.18% |
| 3 | Industrials | 10.38% |
| 4 | Financials | 9.91% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Tandem Diabetes Care
TNDM
$1.55B
| $1.28M | 0.02% |
13,148
+5,929
| +82% | +$529K |
|
752
TaskUs
TASK
$719M
| $1.28M | 0.02% |
+37,394
| New | +$1.18M |
|
753
Xerox
XRX
$374M
| $1.28M | 0.02% |
54,433
-313,827
| -85% | -$7.59M |
|
|
BRSL
754
Brightstar Lottery PLC
BRSL
$2.16B
| $1.27M | 0.02% |
53,058
+16,608
| +46% | +$348K |
|
755
OptimizeRx
OPRX
$144M
| $1.27M | 0.02% |
20,532
+16,320
| +387% | +$831K |
|
756
MarineMax
HZO
$1.15B
| $1.27M | 0.02% |
26,022
+18,556
| +249% | +$968K |
|
757
Advanced Energy
AEIS
$11B
| $1.27M | 0.02% |
11,242
-13,741
| -55% | -$1.46M |
|
758
Reinsurance Group of America
RGA
$16B
| $1.26M | 0.02% |
11,095
+9,350
| +536% | +$1.18M |
|
759
Editas Medicine
EDIT
$461M
| $1.26M | 0.02% |
+22,266
| New | +$822K |
|
760
US Physical Therapy
USPH
$1.15B
| $1.26M | 0.02% |
10,845
+5,495
| +103% | +$631K |
|
|
CCV.U
761
DELISTED
Churchill Capital Corp V Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable warrant
CCV.U
| $1.26M | 0.02% |
118,824
-46,207
| -28% | -$480K |
|
762
Outset Medical
OM
$78.2M
| $1.25M | 0.02% |
+1,671
| New | +$1.28M |
|
763
Louisiana-Pacific
LPX
$5.08B
| $1.25M | 0.02% |
20,762
-151
| -0.7% | -$9.65K |
|
764
Charles River Laboratories
CRL
$14.3B
| $1.25M | 0.02% |
3,368
-10,418
| -76% | -$3.48M |
|
|
GMS
765
DELISTED
GMS Inc
GMS
| $1.24M | 0.02% |
25,755
+18,533
| +257% | +$823K |
|
|
OSI.U
766
DELISTED
Osiris Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant
OSI.U
| $1.24M | 0.02% |
+124,890
| New | +$1.24M |
|
767
EQT Corp
EQT
$33.6B
| $1.23M | 0.02% |
55,278
-12,131
| -18% | -$245K |
|
768
Ocugen
OCGN
$461M
| $1.23M | 0.02% |
153,022
+71,058
| +87% | +$600K |
|
769
Olin
OLN
$2B
| $1.22M | 0.02% |
26,414
+12,693
| +93% | +$572K |
|
770
RB Global
RBA
$15.6B
| $1.22M | 0.02% |
+20,583
| New | +$1.27M |
|
771
Orthofix Medical
OFIX
$399M
| $1.22M | 0.02% |
30,379
+12,273
| +68% | +$519K |
|
772
The GEO Group
GEO
$4.24B
| $1.22M | 0.02% |
+170,827
| New | +$1.08M |
|
773
ConocoPhillips
COP
$160B
| $1.22M | 0.02% |
19,946
-26,855
| -57% | -$1.5M |
|
|
HAPN
774
Happen Inc
HAPN
$2.11B
| $1.21M | 0.02% |
+66,971
| New | +$1.04M |
|
775
Merck
MRK
$372B
| $1.21M | 0.02% |
+15,544
| New | +$1.16M |
|
Similar funds
Paul Tudor Jones's Q2 2021 Portfolio in Review
As of Q2 2021, Paul Tudor Jones held 2,186 positions worth $5.29B, up 6.2% from $4.99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Paul Tudor Jones deployed $506M of net new capital in Q2 2021, opening 664 new positions and adding to 387 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 2,502,132 shares worth $115M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was VanEck Semiconductor ETF, an estimated $39.6M trimmed.
- Paul Tudor Jones's largest Q2 2021 buy was PPD, Inc. Common Stock: 2,502,132 shares worth $115M.
- Paul Tudor Jones added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $422M increase.
- Paul Tudor Jones's biggest Q2 2021 reduction was VanEck Semiconductor ETF, cutting an estimated $39.6M.
- Paul Tudor Jones fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $310M.
- Paul Tudor Jones's ten largest holdings make up 19% of its $5.29B portfolio in Q2 2021.
- Paul Tudor Jones opened 664 new positions and closed 625 in Q2 2021.
- Paul Tudor Jones's portfolio value rose 6.2% quarter-over-quarter to $5.29B.
Based on Tudor Investment Corp's 13F filing for Q2 2021, filed 16 Aug 2021.